HDAC9 and brain neoplasm: An increasing number of HDAC inhibitors, such as romidepsin [49], NK-HDAC-1 [50] and Belinostat [51] are being studied in preclinical or clinical research, and we are eager to receive breaking news regarding the treatment of pediatric brain tumors.